ORAL THYROID THERAPEUTIC AGENT Application WO-2018141938-A1 World Intellectual Property Organisation (WIPO) 09 Aug 2018
Stabilized pharmaceutical dosage forms comprising atrasentan Application US-10016393-B2 United States of America 10 Jul 2018